Insider · CIK 0001238120
Phillip B. Donenberg
Files at TECX (AVROBIO, Inc.), TSHA (Taysha Gene Therapies, Inc.), FTH (Sensei Biotherapeutics, Inc.). First filing -, latest -.
In brief
Phillip B. Donenberg files SEC Form 4 as director at TECX (AVROBIO, Inc.), and also at TSHA (Taysha Gene Therapies, Inc.), FTH (Sensei Biotherapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Phillip B. Donenberg has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jun 12, 2026 |
| Jun 9, 2026 | TECX AVROBIO, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,200 | $0.00 | $0 | 10,200 | Jun 10, 2026 |
| Jun 1, 2026 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Common Stock | +21,335 | $0.00 | $0 | 241,289 | Jun 2, 2026 |
| Jun 1, 2026 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Stock Option (right to buy)derivative | +42,671 | $0.00 | $0 | 42,671 | Jun 2, 2026 |
| Apr 10, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +23,100 | $0.00 | $0 | 23,100 | Apr 14, 2026 |
| Feb 13, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,900 | $0.00 | $0 | 1,900 | Feb 17, 2026 |
| Jun 9, 2025 | TECX AVROBIO, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,200 | $0.00 | $0 | 10,200 | Jun 11, 2025 |
| Jun 2, 2025 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Common Stock | +56,623 | $0.00 | $0 | 219,954 | Jun 4, 2025 |
| Jun 2, 2025 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Stock Option (right to buy)derivative | +113,246 | $0.00 | $0 | 113,246 | Jun 4, 2025 |
Questions about Phillip B. Donenberg
Answered from the filings on this page, as of the latest one.
Is Phillip B. Donenberg buying or selling?
Phillip B. Donenberg has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Phillip B. Donenberg's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Phillip B. Donenberg has 0.
Where does Phillip B. Donenberg file Form 4?
Phillip B. Donenberg has filed Form 4 at TECX (AVROBIO, Inc.); TSHA (Taysha Gene Therapies, Inc.); FTH (Sensei Biotherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.